Frost & Sullivan Acclaims TOMTEC's Customer Value Enhancement through Integrated Cardiovascular Imaging Workflow Solutions
TOMTEC's offerings stand out for their value along the continuum of care, notably improving the cardiovascular workflow in risk management and therapy monitoring
MOUNTAIN VIEW, Calif., Nov. 28, 2016 /PRNewswire/ -- Based on its ongoing analysis of the cardiovascular imaging informatics market, Frost & Sullivan recognizes TOMTEC with the 2016 North America Frost & Sullivan Award for Customer Value Leadership. TOMTEC is emerging as a name to reckon with, especially in the US market, as it rolls out clinical automation, risk management, and therapy monitoring solutions. Its upgraded offerings serve the broader cardiovascular continuum of care by combining advanced imaging interpretation techniques with state-of-the-art workflow solutions.
The Munich-based company has won global recognition for its leading-edge visualization tools for cardiology and radiology imaging. From an advanced applications developer, it has evolved into a vendor of powerful cardiovascular workflow and decision support solutions, including risk management and therapy monitoring, leveraging cutting-edge deep learning technology.
"In line with the current trends, TOMTEC's solution portfolio has been expanded to cover the entire gamut of cardiovascular imaging modalities, and has been re-engineered using the latest zero-footprint IT standards," said Frost & Sullivan Industry Analyst Dinesh Kumar. "Its vendor-agnostic platform aids seamless connectivity with existing hospital IT systems, thereby enabling tighter integration of stakeholders along the care pathway in facilities of all sizes, even those with complex workflow environments."
TOMTEC was among the early movers in the clinical workflow automation space. In its endeavor to present actionable clinical data, it developed deep learning algorithms that automatically extract features and train various applications, including those for clinical validations. This ensures the delivery of high-quality, validated, and user-independent results for clinical decision support and helps serve as a foundation for data mining in electronic medical records (EMR) for population health management (PHM).
One of the prominent application areas of TOMTEC's workflow automation solutions is the congestive heart failure (CHF) patient population. Caregivers that employ the company's automated image recognition and workflow automation tools are able to measure and monitor their patients in real time. Such an integrated approach makes possible for accurate assessments of early and late stages of heart failure by tracking subclinical deterioration of the heart.
As part of its clinical integration efforts, TOMTEC's cardio-oncology solution resolves the critical side-effects of existing procedures, such as cardio-toxicity. Supporting proprietary technology from its partners, the company ensures precise detection, assessment, and quantification of abnormalities. The integrated management of patient-specific conditions paves the way to more personalized treatments and overall robust patient outcomes.
"One of the most important value propositions of TOMTEC's solutions is their customer centricity," noted Kumar. "Despite competing against much larger vendors providing broad-based imaging IT solutions, TOMTEC's focus on developing a next-generation solution within its core area of expertise sets it apart from the competition in the North American market."
Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in implementing strategies that proactively create value for its customers with a focus on improving the return on the investment that customers make in its services or products. The award recognizes the company's inordinate focus on augmenting the value that its customers receive, beyond simply good customer service, leading to improved customer retention and ultimately customer base expansion.
Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.
About TOMTEC
TOMTEC IMAGING SYSTEMS GMBH, with headquarter located in Munich / Germany, is a worldwide leader for medical image software solutions. Specialized in cardiology it offers state-of-the-art solutions for clinical customers and industry partners.
The products encompass a wide range of 2D and 3D/4D technology for visualization, automated analysis, quantification, reporting and image management. TOMTEC products are available for adult and pediatric cardiology, obstetrics, gynecology, radiology and vascular diagnostics. Moreover, TOMTEC offers a sustainable full-service component in sales and an education program with best-practice sharing among professionals.
The company claim "Excellence in Digital Healthcare" represents striving for excellent image and analysis quality, ease-of-use, reproducibility of automated measurements and an all-around service- and education offering.
The company maintains close working relationships with many leading universities and research institutes around the world.
Visit TOMTEC's website at www.tomtec.de
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector, and the investment community. Contact us: Start the discussion.
Contact:
Chiara Carella
P: +44 (0) 207.343.8314
F: 210.348.1003
E: [email protected]
Photo - http://photos.prnewswire.com/prnh/20161128/443190
SOURCE Frost & Sullivan
Share this article